Episode 121: AML Series, Pt 7 - AML Consolidation: Role of Allogeneic Transplant
The Fellow on Call: The Heme/Onc Podcast
00:00
Integrating MRD Testing in AML Management
This chapter examines the role of minimal residual disease (MRD) testing in the treatment of acute myeloid leukemia (AML) for patients with favorable risk cytogenetics. It discusses how MRD status can guide critical treatment decisions, potentially reducing unnecessary allogeneic transplants while ensuring positive survival rates.
Transcript
Play full episode
